(Q95308075)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32428379%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

4 references

13 July 2022

22 August 2022

22 October 2022

24 October 2022

Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32428379%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

1 reference

1 reference

0 references

Oleg O Glebov

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32428379%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

language of work or name

English

0 references

publication date

19 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32428379%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

1 September 2020

4 references

13 July 2022

22 August 2022

22 October 2022

24 October 2022

5 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32428379%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

13 July 2022

22 August 2022

22 October 2022

24 October 2022

Creative Commons Attribution

4 references

13 July 2022

22 August 2022

22 October 2022

24 October 2022

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7276759

Discovering drugs to treat coronavirus disease 2019 (COVID-19)

10 February 2021

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

A pneumonia outbreak associated with a new coronavirus of probable bat origin

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Virus entry by endocytosis

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Mechanisms of endocytosis

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Canine respiratory coronavirus employs caveolin-1-mediated pathway for internalization to HRT-18G cells.

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Lipid rafts are involved in SARS-CoV entry into Vero E6 cells

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

COVID-19: consider cytokine storm syndromes and immunosuppression

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Endocytic pathways in the olfactory and vomeronasal epithelia of the mouse: ultrastructure and uptake of tracers

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Internalization of Mycobacterium tuberculosis by macropinocytosis in non-phagocytic cells.

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Temporal transcriptional response during infection of type II alveolar epithelial cells with Francisella tularensis live vaccine strain (LVS) supports a general host suppression and bacterial uptake by macropinocytosis

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35.

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Host cell kinases, α5 and β1 integrins, and Rac1 signalling on the microtubule cytoskeleton are important for non-typable Haemophilus influenzae invasion of respiratory epithelial cells

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

COVID-19 and smoking: A systematic review of the evidence

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model.

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

TRAIL-death receptor endocytosis and apoptosis are selectively regulated by dynamin-1 activation.

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Interleukin-33 enhances programmed oncosis of ST2L-positive low-metastatic cells in the tumour microenvironment of lung cancer.

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Isolation and culture of human alveolar epithelial cells

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Endocytosis unplugged: multiple ways to enter the cell

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Clathrin-independent trafficking of AMPA receptors.

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Molecular mechanisms of clathrin-independent endocytosis.

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Pitstop 2 is a potent inhibitor of clathrin-independent endocytosis

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Excitement around hydroxychloroquine for treating COVID-19 causes challenges for rheumatology

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Some selective serotonin reuptake inhibitors inhibit dynamin I guanosine triphosphatase (GTPase).

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Suppression of dynamin GTPase activity by sertraline leads to inhibition of dynamin-dependent endocytosis.

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Antihistamines in bronchial asthma.

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Direct Engagement of TLR9 Ligand with T Helper Cells Leads to Cell Proliferation & Up-regulation of Cytokines

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration, and rheology of sputum

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Identification of novel macropinocytosis inhibitors using a rational screen of Food and Drug Administration-approved drugs

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Vinblastine but not other microtubule inhibitors block transferrin endocytosis and iron uptake by reticulocytes

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation

24 July 2020

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276759

Pulmonary moniliasis treated with nystatin aerosol

24 July 2020

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7276759

Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase I

10 February 2021

0 references

Potential of in vitro reconstituted 3D human airway epithelia (MucilAir™) to assess respiratory sensitizers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7276759

ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19

10 February 2021

0 references

The protein expression profile of ACE2 in human tissues

0 references

COVID‐19: Lessons from SARS and MERS

0 references

Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7276759

The protein expression profile of ACE2 in human tissues

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7276759

Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7276759

ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7276759

Evidence for Nanoparticle-Induced Lysosomal Dysfunction in Lung Adenocarcinoma (A549) Cells

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7276759

Targeting viral entry as a strategy for broad-spectrum antivirals

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7276759

Characterization of air-liquid interface culture of A549 alveolar epithelial cells

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7276759

Entry of human coronavirus NL63 to the cell.

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7276759

10 February 2021

Identifiers

DOI

10.1111/FEBS.15369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32428379%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

24 May 2020

COVIDWHO ID

covidwho-306173

0 references

1127707473

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

DOI

10.6084/M9.FIGSHARE.11961063

28 May 2020

PMC publication ID

7276759

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32428379%20AND%20SRC:MED&resulttype=core&format=json